In contrast, cell proliferation of DMS114 cells was slowed down efficiently by both versions of Spry4, but the protein adaptation created based on the alteration found in Kallmann-syndrome patients inhibited the process to a greater extent. This evidence concerns the gene SPRY4 and Kallmann syndrome.